Skip to content
Home/Companies/Biotech/Tacalyx
TA

Tacalyx

Biotech·Germany·Active·7yr hold

Tacalyx is a healthcare company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Tacalyx?

Tacalyx is currently owned by Creathor Ventures through Creathor Venture Fund IV (2018 vintage), since 2019. Across its history, Tacalyx has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Creathor Ventures
Most recent investor
Creathor Ventures
Creathor Venture Fund IV · 2018 · Evergreen
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Boehringer Ingelheim Venture Fund, Creathor Ventures and Kurma Partners since 2019.
Co-invest · 2 holders · 2019 · present
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2019 · present · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
MOIC
–
Creathor Ventures
Creathor VenturesActive
2019 · present · Creathor Venture Fund IV · 2018 · Evergreen
MOIC
–
Kurma Partners
Kurma PartnersActive
present · Kurma Biofund III · 2018 · VC
MOIC
–

More from Creathor Venture Fund IV

Other portfolio companies in the same fund.

HeyJobs
Active
SoftwareGermany· 2019
lengoo
Active
SoftwareGermany· 2019
Acousia Therapeutics
Active
PharmaGermany· 2018
Ledgy
Active
FintechSwitzerland· 2018
Wunderflats
Active
SoftwareGermany· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings